APRIL 2023LIFE SCIENCES REVIEW4CONTENTS12LAST WORDIN MY OPINION08The Cancer Immunotherapy Treatment ParadigmCharles G. Drake, M.D., Ph.D.,Vice President,Immuno-Oncology,The Janssen Pharmaceutical Companies of Johnson & Johnson30The Challenging Aspects of Developing AI/ML-Based Diagnostic Pathology PlatformsDr. Kim M. Bonner, BSc (Hons) VMD PhD,Executive Director,Clinical Development,Syneos HealthCELLEX CELLPROFESSIONALSBRINGING INNOVATIVE CONCEPTS TO THE CLINICCOVER STORYCarla Kreissig, CEO
< Page 3 | Page 5 >